Repligen Corp (RGEN)
167.80
-3.48
(-2.03%)
USD |
NASDAQ |
Apr 24, 16:00
167.51
-0.29
(-0.17%)
After-Hours: 17:58
Repligen Enterprise Value: 9.381B for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 9.381B |
| April 22, 2024 | 8.611B |
| April 19, 2024 | 8.592B |
| April 18, 2024 | 8.588B |
| April 17, 2024 | 8.806B |
| April 16, 2024 | 8.984B |
| April 15, 2024 | 9.108B |
| April 12, 2024 | 9.395B |
| April 11, 2024 | 9.648B |
| April 10, 2024 | 9.644B |
| April 09, 2024 | 9.974B |
| April 08, 2024 | 9.535B |
| April 05, 2024 | 9.522B |
| April 04, 2024 | 9.473B |
| April 03, 2024 | 9.718B |
| April 02, 2024 | 9.751B |
| April 01, 2024 | 10.03B |
| March 28, 2024 | 10.09B |
| March 27, 2024 | 10.13B |
| March 26, 2024 | 10.08B |
| March 25, 2024 | 10.14B |
| March 22, 2024 | 10.87B |
| March 21, 2024 | 10.97B |
| March 20, 2024 | 10.80B |
| March 19, 2024 | 10.91B |
| Date | Value |
|---|---|
| March 18, 2024 | 10.66B |
| March 15, 2024 | 10.42B |
| March 14, 2024 | 10.62B |
| March 13, 2024 | 10.67B |
| March 12, 2024 | 10.58B |
| March 11, 2024 | 10.60B |
| March 08, 2024 | 10.73B |
| March 07, 2024 | 10.90B |
| March 06, 2024 | 10.71B |
| March 05, 2024 | 10.54B |
| March 04, 2024 | 10.74B |
| March 01, 2024 | 10.73B |
| February 29, 2024 | 10.65B |
| February 28, 2024 | 10.76B |
| February 27, 2024 | 10.58B |
| February 26, 2024 | 10.52B |
| February 23, 2024 | 10.79B |
| February 22, 2024 | 10.61B |
| February 21, 2024 | 10.65B |
| February 20, 2024 | 10.97B |
| February 16, 2024 | 11.45B |
| February 15, 2024 | 11.32B |
| February 14, 2024 | 11.32B |
| February 13, 2024 | 10.90B |
| February 12, 2024 | 11.30B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.376B
Minimum
Apr 24 2019
17.34B
Maximum
Sep 23 2021
8.747B
Average
9.054B
Median
Nov 03 2020
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 990.24M |
| Retractable Technologies Inc | -13.49M |
| Xtant Medical Holdings Inc | 134.44M |
| Asensus Surgical Inc | 46.66M |
| Catheter Precision Inc | 0.0702M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.49M |
| Revenue (Quarterly) | 155.74M |
| Total Expenses (Quarterly) | 155.93M |
| EPS Diluted (Quarterly) | -0.46 |
| Gross Profit Margin (Quarterly) | 43.41% |
| Profit Margin (Quarterly) | -16.37% |
| Earnings Yield | 0.43% |
| Operating Earnings Yield | 0.25% |
| Normalized Earnings Yield | 0.0821 |